US$ 28.05
glp 1 agonist black box warning FDA Says to Drop Suicide From GLP-1 Drug Labels GLP-1 Safety, Ethics & Patient
Description
The resulting increase in vagal toe inhibits gastric emptying and gastric acid secretion, subsequently resulting in a delay of gastric emptying, and reduction of glucose absorption (Shaefer et al, 2015)

doi: 10.1111/j.1464-5491.2012.03738.x

Metabolism 12, 8287

Anti-obesity medications and investigational agents: an Obesity Medicine Association (OMA) clinical practice statement (CPS) 2022

doi: 10.1210/endo.143.6.8840
